US Stock MarketDetailed Quotes

NKGen Biotech (NKGN)

Watchlist
  • 0.0600
  • 0.00000.00%
15min DelayTrading Jan 22 13:59 ET
2.72MMarket Cap-0.02P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

NKGen Biotech (NKGN) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
0
Gross profit
0
Operating expense
-38.77%4.67M
-9.35%26.97M
-45.93%5.1M
-1.67%6.79M
12.80%7.46M
12.11%7.62M
21.88%29.75M
51.03%9.43M
15.15%6.9M
6.61M
Selling and administrative expenses
-35.94%2.81M
15.85%16.31M
-33.65%3.54M
34.84%4.01M
70.61%4.37M
37.07%4.39M
83.81%14.08M
147.50%5.34M
58.70%2.97M
--2.56M
-General and administrative expense
-35.94%2.81M
15.85%16.31M
-33.65%3.54M
34.84%4.01M
70.61%4.37M
37.07%4.39M
83.81%14.08M
147.50%5.34M
58.70%2.97M
--2.56M
Research and development costs
-42.61%1.86M
-31.99%10.66M
-61.97%1.56M
-29.29%2.78M
-23.78%3.09M
-10.09%3.24M
-6.44%15.67M
0.10%4.09M
-4.66%3.93M
--4.05M
Operating profit
38.77%-4.67M
9.35%-26.97M
45.93%-5.1M
1.67%-6.79M
-12.80%-7.46M
-12.11%-7.62M
-22.18%-29.75M
-50.67%-9.43M
-15.20%-6.9M
-6.61M
Net non-operating interest income expense
13.29%-1.56M
-13.73%-28.68M
-6.35%-26.5M
-123.70%-472K
-943.55%-647K
-5,188.24%-1.8M
-993.67%-25.22M
-3,944.32%-24.91M
66.82%-211K
-62K
Non-operating interest expense
-52.39%509K
265.64%2.72M
22.37%536K
123.70%472K
943.55%647K
3,044.12%1.07M
-67.69%745K
-28.90%438K
-66.82%211K
--62K
Total other finance cost
44.03%1.05M
6.06%25.96M
----
----
----
--729K
--24.48M
----
----
----
Other net income (expense)
434.43%21.58M
140.80%11.42M
199.60%2.24M
153.17%13.86M
-578.91%-7.98M
370.94%4.04M
-29,353.68%-27.98M
1,247.69%746K
-39,996.92%-26.06M
-1.18M
Gain on sale of security
20.71%5.47M
146.11%11.42M
17.48%-19.58M
867.78%16.85M
910.21%10.4M
--4.53M
---24.77M
---23.73M
--1.74M
---1.28M
Special income (charges)
----
--0
--0
--0
----
----
---3.33M
--0
---3.33M
----
-Less：Restructuring and merger&acquisition
----
--0
--0
--0
----
----
--3.33M
--0
--3.33M
----
Other non- operating income (expenses)
3,339.84%16.1M
-105.00%-6K
-10.86%21.82M
87.78%-2.99M
-17,276.64%-18.38M
66.64%-497K
226.32%120K
37,753.85%24.48M
-37,553.85%-24.48M
--107K
Income before tax
385.21%15.35M
46.67%-44.23M
12.61%-29.36M
119.89%6.6M
-104.97%-16.09M
35.33%-5.38M
-210.12%-82.95M
-384.07%-33.6M
-395.70%-33.18M
-7.85M
Income tax
657.14%53K
657.14%53K
0
0
0.00%7K
0.00%7K
0
0
Net income
385.21%15.35M
46.61%-44.29M
12.47%-29.41M
119.89%6.6M
-104.97%-16.09M
35.33%-5.38M
-210.06%-82.95M
-383.68%-33.61M
-395.70%-33.18M
-7.85M
Net income continuous Operations
385.21%15.35M
46.61%-44.29M
12.47%-29.41M
119.89%6.6M
-104.97%-16.09M
35.33%-5.38M
-210.06%-82.95M
-383.68%-33.61M
-395.70%-33.18M
---7.85M
Minority interest income
Net income attributable to the parent company
385.21%15.35M
46.61%-44.29M
12.47%-29.41M
119.89%6.6M
-104.97%-16.09M
35.33%-5.38M
-210.06%-82.95M
-383.68%-33.61M
-395.70%-33.18M
-7.85M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
385.21%15.35M
46.61%-44.29M
12.47%-29.41M
119.89%6.6M
-104.97%-16.09M
35.33%-5.38M
-210.06%-82.95M
-383.68%-33.61M
-395.70%-33.18M
-7.85M
Basic earnings per share
232.00%0.33
71.38%-1.54
43.45%-0.95
109.27%0.23
-86.85%-0.67
2.06%-0.25
-555.62%-5.38
-688.33%-1.68
-1,108.06%-2.48
-0.3586
Diluted earnings per share
84.00%-0.04
71.38%-1.54
43.45%-0.95
106.05%0.15
-86.85%-0.67
2.06%-0.25
-555.62%-5.38
-688.33%-1.68
-1,108.06%-2.48
-0.3586
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue 0
Gross profit 0
Operating expense -38.77%4.67M-9.35%26.97M-45.93%5.1M-1.67%6.79M12.80%7.46M12.11%7.62M21.88%29.75M51.03%9.43M15.15%6.9M6.61M
Selling and administrative expenses -35.94%2.81M15.85%16.31M-33.65%3.54M34.84%4.01M70.61%4.37M37.07%4.39M83.81%14.08M147.50%5.34M58.70%2.97M--2.56M
-General and administrative expense -35.94%2.81M15.85%16.31M-33.65%3.54M34.84%4.01M70.61%4.37M37.07%4.39M83.81%14.08M147.50%5.34M58.70%2.97M--2.56M
Research and development costs -42.61%1.86M-31.99%10.66M-61.97%1.56M-29.29%2.78M-23.78%3.09M-10.09%3.24M-6.44%15.67M0.10%4.09M-4.66%3.93M--4.05M
Operating profit 38.77%-4.67M9.35%-26.97M45.93%-5.1M1.67%-6.79M-12.80%-7.46M-12.11%-7.62M-22.18%-29.75M-50.67%-9.43M-15.20%-6.9M-6.61M
Net non-operating interest income expense 13.29%-1.56M-13.73%-28.68M-6.35%-26.5M-123.70%-472K-943.55%-647K-5,188.24%-1.8M-993.67%-25.22M-3,944.32%-24.91M66.82%-211K-62K
Non-operating interest expense -52.39%509K265.64%2.72M22.37%536K123.70%472K943.55%647K3,044.12%1.07M-67.69%745K-28.90%438K-66.82%211K--62K
Total other finance cost 44.03%1.05M6.06%25.96M--------------729K--24.48M------------
Other net income (expense) 434.43%21.58M140.80%11.42M199.60%2.24M153.17%13.86M-578.91%-7.98M370.94%4.04M-29,353.68%-27.98M1,247.69%746K-39,996.92%-26.06M-1.18M
Gain on sale of security 20.71%5.47M146.11%11.42M17.48%-19.58M867.78%16.85M910.21%10.4M--4.53M---24.77M---23.73M--1.74M---1.28M
Special income (charges) ------0--0--0-----------3.33M--0---3.33M----
-Less：Restructuring and merger&acquisition ------0--0--0----------3.33M--0--3.33M----
Other non- operating income (expenses) 3,339.84%16.1M-105.00%-6K-10.86%21.82M87.78%-2.99M-17,276.64%-18.38M66.64%-497K226.32%120K37,753.85%24.48M-37,553.85%-24.48M--107K
Income before tax 385.21%15.35M46.67%-44.23M12.61%-29.36M119.89%6.6M-104.97%-16.09M35.33%-5.38M-210.12%-82.95M-384.07%-33.6M-395.70%-33.18M-7.85M
Income tax 657.14%53K657.14%53K000.00%7K0.00%7K00
Net income 385.21%15.35M46.61%-44.29M12.47%-29.41M119.89%6.6M-104.97%-16.09M35.33%-5.38M-210.06%-82.95M-383.68%-33.61M-395.70%-33.18M-7.85M
Net income continuous Operations 385.21%15.35M46.61%-44.29M12.47%-29.41M119.89%6.6M-104.97%-16.09M35.33%-5.38M-210.06%-82.95M-383.68%-33.61M-395.70%-33.18M---7.85M
Minority interest income
Net income attributable to the parent company 385.21%15.35M46.61%-44.29M12.47%-29.41M119.89%6.6M-104.97%-16.09M35.33%-5.38M-210.06%-82.95M-383.68%-33.61M-395.70%-33.18M-7.85M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 385.21%15.35M46.61%-44.29M12.47%-29.41M119.89%6.6M-104.97%-16.09M35.33%-5.38M-210.06%-82.95M-383.68%-33.61M-395.70%-33.18M-7.85M
Basic earnings per share 232.00%0.3371.38%-1.5443.45%-0.95109.27%0.23-86.85%-0.672.06%-0.25-555.62%-5.38-688.33%-1.68-1,108.06%-2.48-0.3586
Diluted earnings per share 84.00%-0.0471.38%-1.5443.45%-0.95106.05%0.15-86.85%-0.672.06%-0.25-555.62%-5.38-688.33%-1.68-1,108.06%-2.48-0.3586
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +2.39%
Sample Name
Sample Code
 +2.22%
Sample Name
Sample Code
 +2.06%
4
Clean Energy Fuels
CLNE
+1.75%
5
NVIDIA
NVDA
+1.49%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +18.76%
Sample Name
Sample Code
 +8.15%
Sample Name
Sample Code
 +4.23%
4
KE Holdings
BEKE
+3.82%
5
Pony AI
PONY
+3.34%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -